YOSHITSU CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2253 USD | -4.29% |
|
-3.72% | -67.85% |
| 04-23 | Yoshitsu Co., Ltd Sets Its Sights on the US, Gears Up for More Brick-And-Mortar Expansion | CI |
| 03-15 | ADRs End Lower; Akso Health Group Declines 23% | DJ |
| Sales 2022 | 228M 314M | Sales 2023 | 170M 234M | Capitalization | 35.53M 48.89M |
|---|---|---|---|---|---|
| Net income 2022 | 3M 4.13M | Net income 2023 | -8M -11.01M | EV / Sales 2022 | 0.54 x |
| Net Debt 2022 | 47.11M 64.84M | Net Debt 2023 | 75.71M 104M | EV / Sales 2023 | 0.66 x |
| P/E ratio 2022 |
21.2
x | P/E ratio 2023 |
-4.41
x | Employees | 135 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.94% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.29% | ||
| 1 week | -3.72% | ||
| Current month | -8.82% | ||
| 1 month | +1.30% | ||
| 3 months | -15.11% | ||
| 6 months | -71.60% | ||
| Current year | -67.85% |
1 week
0.22
0.25
1 month
0.200.52
Current year
0.200.82
1 year
0.201.47
3 years
0.2043.00
5 years
0.2043.00
10 years
0.2043.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mei Kanayama
CEO | Chief Executive Officer | 44 | 07-12-31 |
Yoichiro Haga
DFI | Director of Finance/CFO | 57 | 20-08-31 |
Xu Wang
AUD | Comptroller/Controller/Auditor | 42 | 21-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mei Kanayama
CEO | Chief Executive Officer | 44 | 07-12-31 |
Sen Uehara
BRD | Director/Board Member | 43 | 20-02-29 |
Yoichiro Haga
DFI | Director of Finance/CFO | 57 | 20-08-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-10 | 0.2253 | -4.29% | 481,113 |
| 24-06-07 | 0.2354 | -3.60% | 182,788 |
| 24-06-06 | 0.2442 | +3.91% | 191,548 |
| 24-06-05 | 0.235 | -4.47% | 307,764 |
| 24-06-04 | 0.246 | +5.13% | 925,339 |
Delayed Quote Nasdaq, June 10, 2024 at 04:30 pm
More quotes
Yoshitsu Co Ltd is a Japan-based company mainly engaged in the management of pharmacy and sale of health products, beauty products and other groceries. The Company is engaged in the supply of health products include over-the-counter (OTC) drugs, nutritional supplements, and medical supplies and devices. Its beauty products include cosmetics, skin care, fragrance, and body care. Its other products include lingerie, home goods, food, and alcoholic beverages. The Company distributes its products through physical stores, online stores, and franchise stores and wholesale customers.
Sector
Drug Retailers
Calendar
2024-08-11
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -67.85% | 9.94M | |
| -38.95% | 13.67B | |
| -35.29% | 10.33B | |
| -8.96% | 7.95B | |
| +4.90% | 5.86B | |
| -14.98% | 5.71B | |
| -2.04% | 4.6B | |
| +69.95% | 4.5B | |
| -8.55% | 3.77B | |
| -22.05% | 3.05B |
- Stock Market
- Equities
- TKLF Stock
